Study for Assessing the Prevalence of Airflow Limitation in Outpatients With History of Smoking Attending Cardiology Clinics | MicrobiomeTrials← Back to trialsNCT07315958
Study for Assessing the Prevalence of Airflow Limitation in Outpatients With History of Smoking Attending Cardiology Clinics
RecruitingOBSERVATIONAL
Trial Details
Start: 2025-10-08Est. Completion: 2026-09-30
Enrollment target: 1,000 participants Locations- Research Site, Ankara, Turkey (Türkiye)
- Research Site, Istanbul, Turkey (Türkiye)
Other microbiome trials you might be interested in
SARS-CoV-2Influenza, HumanRespiratory Syncytial Virus InfectionsRespiratory Distress SyndromeSystemic Inflammatory Response Syndrome
The purpose of this clinical trial is to evaluate the safety, tolerability and efficacy of two doses (dose A and dose B)…
Alcalá de Henares, SpainEst. completion Oct 2, 2026
Pulmonary Disease (COPD), Chronic ObstructiveLung Resection Surgery
This study investigates the effects of three extrinsic PEEP settings-5 cmH2O, 0 cmH2O, and an individualized PEEP (70% o…
Multiple LocationsEst. completion May 31, 2027
Chronic Obstructive Pulmonary DiseaseCOPD
ROMEO is a Phase III, multicentre, open-label, chronic-dosing extension study evaluating the long-term safety of two dos…
Aix-en-Provence, FranceEst. completion Dec 29, 2028